Adaptive Biotechnologies Corporation (NASDAQ:ADPT) went down by -1.87% during the previous trading session, and it is maintaining the win ahead of Tuesday’s trading session. The share price of the Biotechnology giant went up by $43.65 to trade ended Tuesday trading at $44.48. This is down from the $44.48 price recorded on Monday’s trading session. Thanks to this latest performance, ADPT is closer to the higher price 52-week target of $60.00 and further from the lowest price target of $45.00. Its performance from the start of the year has also been positive, with ADPT up by 45.89% year-to-date.
Adaptive Biotechnologies Corporation (ADPT) started the day trading at $44.9 and recorded an intraday high of $45.17. It also recorded an intraday low of $43.03 during Tuesday’s trading session. Adaptive Biotechnologies Corporation is a very active stock that recorded a trading volume that is more than 2.45% of the average daily trading volume on Tuesday. The stock’s trading volume on Tuesday was 1117367, which is more than 2.45 of the total average daily trading volume of 1.09 million.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) 2020 Performance Impressive
The increase in ADPT’s stock price on Tuesday saw its overall performance boost over the past few months. We can quantify the performance of the stock so far this year using a few metrics. The 52-week high price of ADPT currently stands at $55.12, which is higher than the current trading price of the stock by 20.81%. However, ADPT’s current trading price is -187.36% lower than the 52-week low price of $15.19. In terms of trading volume, Adaptive Biotechnologies Corporation currently experienced healthy participation during the last trading session. 1117367 shares of Adaptive Biotechnologies Corporation were traded on the stock exchange on Tuesday, which is more than 2.45% of the 1.09 million average trading volume of the stock.
The performance of the stock has been positive over the past year. ADPT’s stock has gone up by 44.54% in the last six months. The quarterly performance of ADPT currently stands at 142.37%, and it is up by 14.75% in the last month. The only positive figure was from the weekly performance, which currently reads 5.18%. At the time of writing ADPT’s report, the company has a total market cap of $5.43B, making it one of the largest publicly-traded companies in the world.Adaptive Biotechnologies Corporation also has over 453 employees all over the world.
ADPT Insider Activities
For Adaptive Biotechnologies Corporation, insiders hold 76.30% of all company shares. The insider transactions over the past six months are down by -116.70%. During that period, insiders bought 1,964,894 shares in 88 transactions. In that same period, insiders sold 14,371,793 of their shares in 111 transactions. After these transactions, insiders at Adaptive Biotechnologies Corporation now hold 6.94M shares, which is over 73.44% of the total company stocks. Institutional investors currently hold a large chunk of the ADPT shares, as they control 5.47% of the company’s total stock.
ADPT Fundamental Analysis
For Adaptive Biotechnologies Corporation, the stock’s diluted earnings per share (EPS) stands at -0.66. In the coming year, analysts expect the EPS to be -1.09.
The Return on Investment (ROI) on Adaptive Biotechnologies Corporation’s stock currently stands at -12.90%, and it has a net profit margin of -88.20%. The operating margin of the company is -99.60%, and its gross margin is 75.70%.
At the moment, Adaptive Biotechnologies Corporation’s Total Debt to Equity ratio stands at 0.00, and they have a long-term Debt to Equity ratio of 0.00.
ADPT Technical Analysis
The Simple Moving Average (SMA) is one of the most powerful technical indicators. The 20-day Simple Moving Average of ADPT currently stands at 8.21%, while the SMA50 is 25.61%. The biggest one is the SMA200, which is currently reading 39.30% ahead of Tuesday’s trading session. The Relative Strength Index of this stock is 65.87.